Navamedic Asa Stock Last Dividend Paid
| NAVA Stock | NOK 24.50 0.50 2.00% |
Navamedic ASA fundamentals help investors to digest information that contributes to Navamedic ASA's financial success or failures. It also enables traders to predict the movement of Navamedic Stock. The fundamental analysis module provides a way to measure Navamedic ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Navamedic ASA stock.
Navamedic |
Navamedic ASA Company Last Dividend Paid Analysis
Navamedic ASA's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Navamedic ASA has a Last Dividend Paid of 0.0. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Norway stocks average (which is currently at 0.0).
Navamedic Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Navamedic ASA's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Navamedic ASA could also be used in its relative valuation, which is a method of valuing Navamedic ASA by comparing valuation metrics of similar companies.Navamedic ASA is currently under evaluation in last dividend paid category among its peers.
Navamedic Fundamentals
| Return On Equity | 0.073 | |||
| Return On Asset | 0.0633 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 578.31 M | |||
| Shares Outstanding | 16.35 M | |||
| Shares Owned By Insiders | 41.56 % | |||
| Shares Owned By Institutions | 14.08 % | |||
| Price To Earning | 9.39 X | |||
| Price To Book | 3.04 X | |||
| Price To Sales | 1.57 X | |||
| Revenue | 278.44 M | |||
| Gross Profit | 111.74 M | |||
| EBITDA | 11.57 M | |||
| Net Income | 2.36 M | |||
| Cash And Equivalents | 52.62 M | |||
| Cash Per Share | 1.28 X | |||
| Total Debt | 44.8 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 1.17 X | |||
| Book Value Per Share | 9.25 X | |||
| Cash Flow From Operations | (1.3 M) | |||
| Earnings Per Share | 0.46 X | |||
| Target Price | 46.0 | |||
| Number Of Employees | 28 | |||
| Beta | 0.47 | |||
| Market Capitalization | 539.41 M | |||
| Total Asset | 330.18 M | |||
| Retained Earnings | (62 M) | |||
| Working Capital | 15 M | |||
| Current Asset | 131 M | |||
| Current Liabilities | 116 M | |||
| Z Score | 7.2 | |||
| Net Asset | 330.18 M |
About Navamedic ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Navamedic ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Navamedic ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Navamedic ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Navamedic Stock
Navamedic ASA financial ratios help investors to determine whether Navamedic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Navamedic with respect to the benefits of owning Navamedic ASA security.